Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 639107, 13 pages
http://dx.doi.org/10.1155/2015/639107
Review Article

Complexity and Controversies over the Cytokine Profiles of T Helper Cell Subpopulations in Tuberculosis

1Laboratory of Immunology, Federal University of Triangulo Mineiro, 38025-180 Uberaba, MG, Brazil
2Department of Pathology, Institute of Tropical Pathology and Public Health, Federal University of Goias, 74605-050 Goiania, GO, Brazil
3Cefores, Federal University of Triangulo Mineiro, 38015-050 Uberaba, MG, Brazil
4Laboratory of Biopathology and Molecular Biology, University of Uberaba, 38055-500 Uberaba, MG, Brazil

Received 19 November 2014; Accepted 3 February 2015

Academic Editor: Muhammad Atif Zahoor

Copyright © 2015 Marcos Vinicius da Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, Global Tuberculosis Report 2013, 2013.
  2. H. Hartman-Adams, K. Clark, and G. Juckett, “Update on latent tuberculosis infection,” American Family Physician, vol. 89, no. 11, pp. 889–896, 2014. View at Google Scholar · View at Scopus
  3. J. L. Flynn and J. Chan, “Immunology of tuberculosis,” Annual Review of Immunology, vol. 19, pp. 93–129, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Caruso, N. Serbina, E. Klein, K. Triebold, B. R. Bloom, and J. L. Flynn, “Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis,” Journal of Immunology, vol. 162, no. 9, pp. 5407–5416, 1999. View at Google Scholar · View at Scopus
  5. T. Mogues, M. E. Goodrich, L. Ryan, R. LaCourse, and R. J. North, “The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice,” The Journal of Experimental Medicine, vol. 193, no. 3, pp. 271–280, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Geldmacher, A. Zumla, and M. Hoelscher, “Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis,” Current Opinion in HIV and AIDS, vol. 7, no. 3, pp. 268–275, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Cooper, J. Magram, J. Ferrante, and I. M. Orme, “Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis,” The Journal of Experimental Medicine, vol. 186, no. 1, pp. 39–45, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Flynn, J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom, “An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection,” Journal of Experimental Medicine, vol. 178, no. 6, pp. 2249–2254, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Cooper, D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme, “Disseminated tuberculosis in interferon γ gene-disrupted mice,” The Journal of Experimental Medicine, vol. 178, no. 6, pp. 2243–2247, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. B. M. Sullivan, O. Jobe, V. Lazarevic et al., “Increased susceptibility of mice lacking T-bet to infection with Mycobacterium tuberculosis correlates with increased IL-10 and decreased IFN-gamma production,” Journal of Immunology, vol. 175, no. 7, pp. 4593–4602, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J.-L. Casanova and L. Abel, “Genetic dissection of immunity to mycobacteria: the human model,” Annual Review of Immunology, vol. 20, pp. 581–620, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Ashenafi, G. Aderaye, A. Bekele et al., “Progression of clinical tuberculosis is associated with a Th2 immune response signature in combination with elevated levels of SOCS3,” Clinical Immunology, vol. 151, no. 2, pp. 84–99, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Lin, M. Zhang, F. M. Hofman, J. Gong, and P. F. Barnes, “Absence of a prominent Th2 cytokine response in human tuberculosis,” Infection and Immunity, vol. 64, no. 4, pp. 1351–1356, 1996. View at Google Scholar · View at Scopus
  14. S. Winkler, M. Necek, H. Winkler et al., “Increased specific T cell cytokine responses in patients with active pulmonary tuberculosis from Central Africa,” Microbes and Infection, vol. 7, no. 9-10, pp. 1161–1169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Hernández-Pando, H. Orozcoe, A. Sampieri et al., “Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis,” Immunology, vol. 89, no. 1, pp. 26–33, 1996. View at Google Scholar
  16. J. C. Ferraz, F. B. S. Melo, M. F. P. M. Albuquerque, S. M. L. Montenegro, and F. G. C. Abath, “Immune factors and immunoregulation in tuberculosis,” Brazilian Journal of Medical and Biological Research, vol. 39, no. 11, pp. 1387–1397, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. N. D. Marin, S. C. París, V. M. Vélez, C. A. Rojas, M. Rojas, and L. F. García, “Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis,” Tuberculosis (Edinb), vol. 90, no. 4, pp. 252–261, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Geffner, N. Yokobori, J. Basile et al., “Patients with multidrug-resistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains,” Infection and Immunity, vol. 77, no. 11, pp. 5025–5034, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Y. Chen, D. Huang, S. Yao et al., “IL-2 simultaneously expands Foxp3+ T regulatory and T effector cells and confers resistance to severe tuberculosis (TB): implicative treg-T effector cooperation in immunity to TB,” The Journal of Immunology, vol. 188, no. 9, pp. 4278–4288, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. T. J. Scriba, B. Kalsdorf, D.-A. Abrahams et al., “Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response,” Journal of Immunology, vol. 180, no. 3, pp. 1962–1970, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Chen, M. Zhang, M. Liao et al., “Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T cells,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 7, pp. 734–742, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Cruz, S. A. Khader, E. Torrado et al., “Cutting edge: IFN-γ regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection,” The Journal of Immunology, vol. 177, no. 3, pp. 1416–1420, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Cruz, A. G. Fraga, J. J. Fountain et al., “Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis,” Journal of Experimental Medicine, vol. 207, no. 8, pp. 1609–1616, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. A. Khader, G. K. Bell, J. E. Pearl et al., “IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge,” Nature Immunology, vol. 8, no. 4, pp. 369–377, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. T. M. Wozniak, B. M. Saunders, A. A. Ryan, and W. J. Britton, “Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon,” Infection and Immunity, vol. 78, no. 10, pp. 4187–4194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. O. Yoshida, M. Umemura, A. Yahagi et al., “Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung,” Journal of Immunology, vol. 184, no. 8, pp. 4414–4422, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. M. Gallegos, J. W. J. van Heijst, M. Samstein, X. Su, E. G. Pamer, and M. S. Glickman, “A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo,” PLoS Pathogens, vol. 7, no. 5, Article ID e1002052, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Qiu, Y. Huang, J. Chen, D. Qiao, G. Zeng, and J. Cai, “Depletion of IL-22 during culture enhanced antigen-driven IFN-gamma production by CD4+T cells from patients with active TB,” Immunology Letters, vol. 150, no. 1-2, pp. 48–53, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Matthews, K. A. Wilkinson, B. Kalsdorf et al., “Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis,” Tuberculosis, vol. 91, no. 6, pp. 587–593, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Qiao, B. Y. Yang, L. Li et al., “ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection,” Scandinavian Journal of Immunology, vol. 73, no. 4, pp. 330–337, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Li, D. Qiao, X. Fu, S. Lao, X. Zhang, and C. Wu, “Identification of mycobacterium tuberculosis-specific Th1, Th17 and Th22 cells using the expression of CD40L in tuberculous pleurisy,” PLoS ONE, vol. 6, no. 5, Article ID e20165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Behrends, J.-C. Renauld, S. Ehlers, and C. Hölscher, “IL-22 is mainly produced by IFNγ-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection,” PLoS ONE, vol. 8, no. 2, Article ID e57379, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. M. V. da Silva, A. A. Figueiredo, J. R. Machado et al., “T cell activation and proinflammatory cytokine production in clinically cured tuberculosis are time-dependent and accompanied by upregulation of IL-10,” PLoS ONE, vol. 8, no. 6, Article ID e65492, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. S. K. Schwander, M. Torres, E. Sada et al., “Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis,” Journal of Infectious Diseases, vol. 178, no. 5, pp. 1434–1445, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Nemeth, H.-M. Winkler, R. H. Zwick et al., “Recruitment of mycobacterium tuberculosis specific CD4+ T cells to the site of infection for diagnosis of active tuberculosis,” Journal of Internal Medicine, vol. 265, no. 1, pp. 163–168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Walrath, L. Zukowski, A. Krywiak, and R. F. Silver, “Resident Th1-like effector memory cells in pulmonary recall responses to Mycobacterium tuberculosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 1, pp. 48–55, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. T. C. Y. Tsao, C.-C. Huang, W.-K. Chiou, P.-Y. Yang, M.-J. Hsieh, and K.-C. Tsao, “Levels of interferon-γ and interleukin-2 receptor-α for bronchoalveolar lavage fluid and serum were correlated with clinical grade and treatment of pulmonary tuberculosis,” International Journal of Tuberculosis and Lung Disease, vol. 6, no. 8, pp. 720–727, 2002. View at Google Scholar · View at Scopus
  38. B. Nandi and S. M. Behar, “Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection,” The Journal of Experimental Medicine, vol. 208, no. 11, pp. 2251–2262, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Chan, Y. Xing, R. S. Magliozzo, and B. R. Bloom, “Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages,” The Journal of Experimental Medicine, vol. 175, no. 4, pp. 1111–1122, 1992. View at Publisher · View at Google Scholar · View at Scopus
  40. H.-S. S. Choi, P. R. Rai, H. W. Chu, C. Cool, and E. D. Chan, “Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis,” The American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 2, pp. 178–186, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. M. G. Gutierrez, S. S. Master, S. B. Singh, G. A. Taylor, M. I. Colombo, and V. Deretic, “Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages,” Cell, vol. 119, no. 6, pp. 753–766, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. J. L. Flynn, M. M. Goldstein, J. Chan et al., “Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice,” Immunity, vol. 2, no. 6, pp. 561–572, 1995. View at Publisher · View at Google Scholar · View at Scopus
  43. A. G. D. Bean, D. R. Roach, H. Briscoe et al., “Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin,” Journal of Immunology, vol. 162, no. 6, pp. 3504–3511, 1999. View at Google Scholar · View at Scopus
  44. V. P. Mohan, C. A. Scanga, K. Yu et al., “Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology,” Infection and Immunity, vol. 69, no. 3, pp. 1847–1855, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. M. A. Gardam, E. C. Keystone, R. Menzies et al., “Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management,” Lancet Infectious Diseases, vol. 3, no. 3, pp. 148–155, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Keane, “TNF-blocking agents and tuberculosis: new drugs illuminate an old topic,” Rheumatology, vol. 44, no. 6, pp. 714–720, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. X. Xie, F. Li, J.-W. Chen, and J. Wang, “Risk of tuberculosis infection in anti-TNF-α biological therapy: from bench to bedside,” Journal of Microbiology, Immunology and Infection, vol. 47, no. 4, pp. 268–274, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Koga, S. Terawaki, R. Tatsukawa, M. Fujita, S. Imafuku, and J. Nakayama, “Development of miliary tuberculosis related to anti-tumor necrosis factor-alpha inhibitor therapy for pustular psoriasis,” The Journal of Dermatology, vol. 40, no. 6, pp. 476–477, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. H.-M. Surcel, M. Troye-Blomberg, S. Paulie et al., “Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens,” Immunology, vol. 81, no. 2, pp. 171–176, 1994. View at Google Scholar · View at Scopus
  50. G. T. Seah, G. M. Scott, and G. A. W. Rook, “Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis,” Journal of Infectious Diseases, vol. 181, no. 1, pp. 385–389, 2000. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Van Crevel, E. Karyadi, F. Preyers et al., “Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities,” Journal of Infectious Diseases, vol. 181, no. 3, pp. 1194–1197, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Dlugovitzky, A. Torres-Morales, L. Rateni et al., “Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement,” FEMS Immunology and Medical Microbiology, vol. 18, no. 3, pp. 203–207, 1997. View at Publisher · View at Google Scholar · View at Scopus
  53. G. Mazzarella, A. Bianco, F. Perna et al., “T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis,” Clinical and Experimental Immunology, vol. 132, no. 2, pp. 283–288, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. A. D. Howard and B. S. Zwilling, “Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines,” Clinical and Experimental Immunology, vol. 115, no. 3, pp. 428–434, 1999. View at Publisher · View at Google Scholar · View at Scopus
  55. K. J. Erb, J. Kirman, B. Delahunt, W. Chen, and G. Le Gros, “IL-4, IL-5 and IL-10 are not required for the control of M. bovis-BCG infection in mice,” Immunology and Cell Biology, vol. 76, no. 1, pp. 41–46, 1998. View at Publisher · View at Google Scholar · View at Scopus
  56. R. J. North, “Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis,” Clinical and Experimental Immunology, vol. 113, no. 1, pp. 55–58, 1998. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Harris, S. A. De Haro, S. S. Master et al., “T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis,” Immunity, vol. 27, no. 3, pp. 505–517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. B. Jamil, F. Shahid, Z. Hasan et al., “Interferonγ/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis,” Tuberculosis, vol. 87, no. 4, pp. 279–287, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. Z. T. Handzel, V. Barak, Y. Altman et al., “Increased Th1 and Th2 type cytokine production in patients with active tuberculosis,” Israel Medical Association Journal, vol. 9, no. 6, pp. 479–483, 2007. View at Google Scholar · View at Scopus
  60. M. Zhang, Y. Lin, D. V. Iyer, J. Gong, J. S. Abrams, and P. F. Barnes, “T-cell cytokine responses in human infection with Mycobacterium tuberculosis,” Infection and Immunity, vol. 63, no. 8, pp. 3231–3234, 1995. View at Google Scholar · View at Scopus
  61. D. M. Higgins, J. Sanchez-Campillo, A. G. Rosas-Taraco, E. J. Lee, I. M. Orme, and M. Gonzalez-Juarrero, “Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection,” Tuberculosis (Edinb), vol. 89, no. 2, pp. 149–157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Gopal, Y. Lin, N. Obermajer et al., “IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination,” European Journal of Immunology, vol. 42, no. 2, pp. 364–373, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. Z.-J. Ye, M.-L. Yuan, Q. Zhou et al., “Differentiation and recruitment of Th9 cells stimulated by pleural mesothelial cells in human Mycobacterium tuberculosis infection,” PLoS ONE, vol. 7, no. 2, Article ID e31710, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. V. Staudt, E. Bothur, M. Klein et al., “Interferon-regulatory factor 4 is essential for the developmental program of t helper 9 cells,” Immunity, vol. 33, no. 2, pp. 192–202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. M. S. Wilson, C. G. Feng, D. L. Barber et al., “Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections,” Journal of Immunology, vol. 184, no. 8, pp. 4378–4390, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. A. A. Chackerian, J. M. Alt, T. V. Perera, C. C. Dascher, and S. M. Behar, “Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity,” Infection and Immunity, vol. 70, no. 8, pp. 4501–4509, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. A. J. Wolf, B. Linas, G. J. Trevejo-Nuñez et al., “Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo,” Journal of Immunology, vol. 179, no. 4, pp. 2509–2519, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. A. O'Garra, P. S. Redford, F. W. McNab, C. I. Bloom, R. J. Wilkinson, and M. P. R. Berry, “The immune response in tuberculosis,” Annual Review of Immunology, vol. 31, pp. 475–527, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. A. M. Green, R. DiFazio, and J. L. Flynn, “IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection,” Journal of Immunology (Baltimore, Md. : 1950), vol. 190, no. 1, pp. 270–277, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Bhattacharyya, R. Singla, A. B. Dey, and H. K. Prasad, “Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis,” Infection and Immunity, vol. 67, no. 11, pp. 5597–5603, 1999. View at Google Scholar · View at Scopus
  71. J.-S. Lee, C.-H. Song, C.-H. Kim et al., “Profiles of IFN-γ and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis,” Clinical & Experimental Immunology, vol. 128, no. 3, pp. 516–524, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. R. Vankayalapati, B. Wizel, S. E. Weis et al., “Serum cytokine concentrations do not parallel Mycobacterium tuberculosis—induced cytokine production in patients with tuberculosis,” Clinical Infectious Diseases, vol. 36, no. 1, pp. 24–28, 2003. View at Publisher · View at Google Scholar · View at Scopus
  73. C. B. Pereira, M. Palaci, O. H. M. Leite, A. J. S. Duarte, and G. Benard, “Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations,” Microbes and Infection, vol. 6, no. 1, pp. 25–33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. E. Sahiratmadja, B. Alisjahbana, T. de Boer et al., “Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment,” Infection and Immunity, vol. 75, no. 2, pp. 820–829, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. R. Al-Attiyah, A. S. Mustafa, A. T. Abal, N. M. Madi, and P. Andersen, “Restoration of mycobacterial antigen-induced proliferation and interferon-γ responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy,” FEMS Immunology & Medical Microbiology, vol. 38, no. 3, pp. 249–256, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. R. Diel, R. Loddenkemper, S. Niemann, K. Meywald-Walter, and A. Nienhaus, “Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update,” The American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 1, pp. 88–95, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. C. S. Hirsch, Z. Toossi, C. Othieno et al., “Depressed T-cell interferon-γ responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy,” The Journal of Infectious Diseases, vol. 180, no. 6, pp. 2069–2073, 1999. View at Publisher · View at Google Scholar · View at Scopus
  78. F. Dieli, G. Friscia, C. di Sano et al., “Sequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapy,” Journal of Infectious Diseases, vol. 180, no. 1, pp. 225–228, 1999. View at Publisher · View at Google Scholar · View at Scopus
  79. R. J. Wilkinson, H. M. Vordermeier, K. A. Wilkinson et al., “Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy,” Journal of Infectious Diseases, vol. 178, no. 3, pp. 760–768, 1998. View at Publisher · View at Google Scholar · View at Scopus
  80. P. F. Barnes, S. D. Mistry, C. L. Cooper, C. Pirmez, T. H. Rea, and R. L. Modlin, “Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis,” Journal of Immunology, vol. 142, no. 4, pp. 1114–1119, 1989. View at Google Scholar · View at Scopus
  81. C. Nunes-Alves, M. G. Booty, S. M. Carpenter, P. Jayaraman, A. C. Rothchild, and S. M. Behar, “In search of a new paradigm for protective immunity to TB,” Nature Reviews Microbiology, vol. 12, no. 4, pp. 289–299, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. J. L. Flynn and J. Chan, “What's good for the host is good for the bug,” Trends in Microbiology, vol. 13, no. 3, pp. 98–102, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. R. van Crevel, T. H. M. Ottenhoff, and J. W. M. van der Meer, “Innate immunity to Mycobacterium tuberculosis,” Clinical Microbiology Reviews, vol. 15, no. 2, pp. 294–309, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. A. Marchant, A. Amedei, A. Azzurri et al., “Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12,” The American Journal of Respiratory Cell and Molecular Biology, vol. 24, no. 2, pp. 187–194, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. S. B. Bradfute, E. F. Castillo, J. Arko-Mensah et al., “Autophagy as an immune effector against tuberculosis,” Current Opinion in Microbiology, vol. 16, no. 3, pp. 355–365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Harris, S. S. Master, S. A. de Haro et al., “Th1-Th2 polarisation and autophagy in the control of intracellular mycobacteria by macrophages,” Veterinary Immunology and Immunopathology, vol. 128, no. 1&3, pp. 37–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. D. Schmid and C. Münz, “Innate and adaptive immunity through autophagy,” Immunity, vol. 27, no. 1, pp. 11–21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. G. A. W. Rook, R. Hernandez-Pando, K. Dheda, and G. T. Seah, “IL-4 in tuberculosis: implications for vaccine design,” Trends in Immunology, vol. 25, no. 9, pp. 483–488, 2004. View at Google Scholar · View at Scopus
  89. S. Z. Josefowicz, L.-F. Lu, and A. Y. Rudensky, “Regulatory T cells: mechanisms of differentiation and function,” Annual Review of Immunology, vol. 30, pp. 531–564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. R. Ribeiro-Rodrigues, T. Resende Co, R. Rojas et al., “A role for CD4+ CD25+ T cells in regulation of the immune response during human tuberculosis,” Clinical & Experimental Immunology, vol. 144, no. 1, pp. 25–34, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. V. Guyot-Revol, J. A. Innes, S. Hackforth, T. Hinks, and A. Lalvani, “Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis,” The American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 7, pp. 803–810, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. K. Ghoreschi, A. Laurence, X.-P. Yang et al., “Generation of pathogenic TH 17 cells in the absence of TGF-β 2 signalling,” Nature, vol. 467, no. 7318, pp. 967–971, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. L. Li, S.-H. Lao, and C.-Y. Wu, “Increased frequency of CD4+CD25high Treg cells inhibit BCG-specific induction of IFN-γ by CD4+ T cells from TB patients,” Tuberculosis, vol. 87, no. 6, pp. 526–534, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. X. Y. He, L. Xiao, H. B. Chen et al., “T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 29, no. 6, pp. 643–650, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. K. M. Quinn, R. S. McHugh, F. J. Rich et al., “Inactivation of CD4+CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load,” Immunology and Cell Biology, vol. 84, no. 5, pp. 467–474, 2006. View at Publisher · View at Google Scholar · View at Scopus
  96. X. P. Yang, K. Ghoreschi, S. M. Steward-Tharp et al., “Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5,” Nature Immunology, vol. 12, no. 3, pp. 247–254, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. Z. Toossi, P. Gogate, H. Shiratsuchi, T. Young, and J. J. Ellner, “Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculous granulomatous lung lesions,” Journal of Immunology, vol. 154, no. 1, pp. 465–473, 1995. View at Google Scholar · View at Scopus
  98. S. A. Khader, J. E. Pearl, K. Sakamoto et al., “IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available,” Journal of Immunology, vol. 175, no. 2, pp. 788–795, 2005. View at Publisher · View at Google Scholar · View at Scopus
  99. T. Lindenstrøm, J. Woodworth, J. Dietrich, C. Aagaard, P. Andersen, and E. M. Agger, “Vaccine-induced Th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset,” Infection and Immunity, vol. 80, no. 10, pp. 3533–3544, 2012. View at Publisher · View at Google Scholar · View at Scopus
  100. C. J. Murray, K. F. Ortblad, C. Guinovart et al., “Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013,” The Lancet, vol. 384, no. 9947, pp. 1005–1070, 2013. View at Publisher · View at Google Scholar
  101. G. F. Sonnenberg, L. A. Fouser, and D. Artis, “Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22,” Nature Immunology, vol. 12, no. 5, pp. 383–390, 2011. View at Publisher · View at Google Scholar · View at Scopus
  102. M. Veldhoen, C. Uyttenhove, J. van Snick et al., “Transforming growth factor-β ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset,” Nature Immunology, vol. 9, no. 12, pp. 1341–1346, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. Y. Yu, Y. Zhang, S. Hu et al., “Different patterns of cytokines and chemokines combined with IFN-γ production reflect mycobacterium tuberculosis infection and disease,” PLoS ONE, vol. 7, no. 9, Article ID e44944, 2012. View at Publisher · View at Google Scholar · View at Scopus
  104. D. Anbarasu, C. P. Raja, and A. Raja, “Multiplex analysis of cytokines/chemokines as biomarkers that differentiate healthy contacts from tuberculosis patients in high endemic settings,” Cytokine, vol. 61, no. 3, pp. 747–754, 2013. View at Publisher · View at Google Scholar · View at Scopus
  105. Y.-G. Hur, A. C. Crampin, C. Chisambo et al., “Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children,” Clinical and Vaccine Immunology, vol. 21, no. 2, pp. 133–142, 2014. View at Publisher · View at Google Scholar · View at Scopus
  106. B. Wu, C. Huang, M. Kato-Maeda et al., “IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis,” Clinical Immunology, vol. 126, no. 2, pp. 202–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. P. C. Hill, R. H. Brookes, A. Fox et al., “Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from exposure in the Gambia,” PLoS ONE, vol. 1, no. 1, article e68, 2006. View at Publisher · View at Google Scholar · View at Scopus
  108. S. Sakaguchi, “Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses,” Annual Review of Immunology, vol. 22, pp. 531–562, 2004. View at Publisher · View at Google Scholar · View at Scopus
  109. A. T. Endharti, M. Rifa'I, Z. Shi et al., “Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-γ production and proliferation of CD8+ T cells1,” Journal of Immunology, vol. 175, no. 11, pp. 7093–7097, 2005. View at Publisher · View at Google Scholar · View at Scopus
  110. A. O'Garra and P. Vieira, “TH1 cells control themselves by producing interleukin-10,” Nature Reviews Immunology, vol. 7, no. 6, pp. 425–428, 2007. View at Publisher · View at Google Scholar · View at Scopus
  111. J. Zhu, H. Yamane, and W. E. Paul, “Differentiation of effector CD4 T cell populations*,” Annual Review of Immunology, vol. 28, pp. 445–489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. M. J. McGeachy, K. S. Bak-Jensen, Y. Chen et al., “TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology,” Nature Immunology, vol. 8, no. 12, pp. 1390–1397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  113. V. Dardalhon, A. Awasthi, H. Kwon et al., “IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3- effector T cells,” Nature Immunology, vol. 9, no. 12, pp. 1347–1355, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. C. I. Kingsley, M. Karim, A. R. Bushell, and K. J. Wood, “CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses,” Journal of Immunology, vol. 168, no. 3, pp. 1080–1086, 2002. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Miyara and S. Sakaguchi, “Natural regulatory T cells: mechanisms of suppression,” Trends in Molecular Medicine, vol. 13, no. 3, pp. 108–116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  116. R. Bacchetta, M. Bigler, J.-L. Touraine et al., “High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells,” Journal of Experimental Medicine, vol. 179, no. 2, pp. 493–502, 1994. View at Publisher · View at Google Scholar · View at Scopus
  117. H. Groux, A. O'Garra, M. Bigler et al., “A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis,” Nature, vol. 389, no. 6652, pp. 737–742, 1997. View at Publisher · View at Google Scholar · View at Scopus
  118. M. G. Roncarolo, R. Bacchetta, C. Bordignon, S. Narula, and M. K. Levings, “Type 1 T regulatory cells,” Immunological Reviews, vol. 182, pp. 68–79, 2001. View at Publisher · View at Google Scholar · View at Scopus
  119. F. Gerosa, C. Paganin, D. Peritt et al., “Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-γ and interleukin-10,” Journal of Experimental Medicine, vol. 183, no. 6, pp. 2559–2569, 1996. View at Publisher · View at Google Scholar · View at Scopus
  120. L. R. Castellano, D. C. Filho, L. Argiro et al., “Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-γ production,” Human Immunology, vol. 70, no. 6, pp. 383–390, 2009. View at Publisher · View at Google Scholar · View at Scopus
  121. D. Jankovic, M. C. Kullberg, C. G. Feng et al., “Conventional T-bet+Foxp3 Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection,” Journal of Experimental Medicine, vol. 204, no. 2, pp. 273–283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  122. M. Daheshia, N. Kuklin, S. Kanangat, E. Manickan, and B. T. Rouse, “Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10,” The Journal of Immunology, vol. 159, no. 4, pp. 1945–1952, 1997. View at Google Scholar · View at Scopus
  123. D. R. Nelson, G. Y. Lauwers, J. Y. N. Lau, and G. L. Davis, “Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders,” Gastroenterology, vol. 118, no. 4, pp. 655–660, 2000. View at Publisher · View at Google Scholar · View at Scopus
  124. S. Mocellin, F. Marincola, C. R. Rossi, D. Nitti, and M. Lise, “The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle,” Cytokine and Growth Factor Reviews, vol. 15, no. 1, pp. 61–76, 2004. View at Publisher · View at Google Scholar · View at Scopus
  125. C. A. Hunter, L. A. Ellis-Neyes, T. Slifer et al., “IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi,” The Journal of Immunology, vol. 158, no. 7, pp. 3311–3316, 1997. View at Google Scholar · View at Scopus
  126. M. Deckert, S. Soltek, G. Geginat et al., “Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis,” Infection and Immunity, vol. 69, no. 7, pp. 4561–4571, 2001. View at Publisher · View at Google Scholar · View at Scopus
  127. J. Sun, R. Madan, C. L. Karp, and T. J. Braciale, “Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10,” Nature Medicine, vol. 15, no. 3, pp. 277–284, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. R. T. Gazzinelli, M. Wysocka, S. Hieny et al., “In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α,” The Journal of Immunology, vol. 157, no. 2, pp. 798–805, 1996. View at Google Scholar · View at Scopus
  129. Y. Suzuki, A. Sher, G. Yap et al., “IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii,” Journal of Immunology, vol. 164, no. 10, pp. 5375–5382, 2000. View at Publisher · View at Google Scholar · View at Scopus
  130. Y. Belkaid, C. A. Piccirillo, S. Mendez, E. M. Shevach, and D. L. Sacks, “CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity,” Nature, vol. 420, no. 6915, pp. 502–507, 2002. View at Publisher · View at Google Scholar · View at Scopus
  131. P. J. Murray, L. Wang, C. Onufryk, R. I. Tepper, and R. A. Young, “T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection,” Journal of Immunology, vol. 158, no. 1, pp. 315–321, 1997. View at Google Scholar · View at Scopus
  132. J. F. D. Siawaya, N. Beyers, P. van Helden, and G. Walzl, “Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis,” Clinical & Experimental Immunology, vol. 156, no. 1, pp. 69–77, 2009. View at Publisher · View at Google Scholar · View at Scopus
  133. F. Gerosa, C. Nisii, S. Righetti et al., “CD4+ T cell clones producing both interferon-γ and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients,” Clinical Immunology, vol. 92, no. 3, pp. 224–234, 1999. View at Publisher · View at Google Scholar · View at Scopus
  134. K. W. Moore, R. de Waal Malefyt, R. L. Coffman, and A. O'Garra, “Interleukin-10 and the interleukin-10 receptor,” Annual Review of Immunology, vol. 19, pp. 683–765, 2001. View at Publisher · View at Google Scholar · View at Scopus
  135. S. Stäger, A. Maroof, S. Zubairi, S. L. Sanos, M. Kopf, and P. M. Kaye, “Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells,” European Journal of Immunology, vol. 36, no. 7, pp. 1764–1771, 2006. View at Publisher · View at Google Scholar · View at Scopus
  136. C. F. Anderson, M. Oukka, V. J. Kuchroo, and D. Sacks, “CD4+CD25-Foxp3- Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis,” Journal of Experimental Medicine, vol. 204, no. 2, pp. 285–297, 2007. View at Publisher · View at Google Scholar · View at Scopus
  137. A. P. F. do Rosário, T. Lamb, P. Spence et al., “IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection,” The Journal of Immunology, vol. 188, no. 3, pp. 1178–1190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  138. D. F. Fiorentino, M. W. Bond, and T. R. Mosmann, “Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones,” The Journal of Experimental Medicine, vol. 170, no. 6, pp. 2081–20095, 1989. View at Publisher · View at Google Scholar · View at Scopus
  139. S.-H. Im, A. Hueber, S. Monticelli, K.-H. Kang, and A. Rao, “Chromatin-level regulation of the IL10 gene in T cells,” The Journal of Biological Chemistry, vol. 279, no. 45, pp. 46818–46825, 2004. View at Publisher · View at Google Scholar · View at Scopus
  140. H. D. Chang, C. Helbig, L. Tykocinski et al., “Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3,” European Journal of Immunology, vol. 37, no. 3, pp. 807–817, 2007. View at Publisher · View at Google Scholar · View at Scopus
  141. M. Assenmacher, J. Schmitz, and A. Radbruch, “Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-γ and in interleukin-4-expressing cells,” European Journal of Immunology, vol. 24, no. 5, pp. 1097–1101, 1994. View at Publisher · View at Google Scholar · View at Scopus
  142. G. Del Prete, M. De Carli, F. Almerigogna, M. G. Giudizi, R. Biagiotti, and S. Romagnani, “Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production,” Journal of Immunology, vol. 150, no. 2, pp. 353–360, 1993. View at Google Scholar · View at Scopus
  143. A. Roers, L. Siewe, E. Strittmatter et al., “T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation,” The Journal of Experimental Medicine, vol. 200, no. 10, pp. 1289–1297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  144. B. Sawitzki, C. I. Kingsley, V. Oliveira, M. Karim, M. Herber, and K. J. Wood, “IFN-γ production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo,” Journal of Experimental Medicine, vol. 201, no. 12, pp. 1925–1935, 2005. View at Publisher · View at Google Scholar · View at Scopus
  145. D. Jankovic, D. G. Kugler, and A. Sher, “IL-10 production by CD4+ effector T cells: a mechanism for self-regulation,” Mucosal Immunology, vol. 3, no. 3, pp. 239–246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  146. C. Pot, H. Jin, A. Awasthi et al., “Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells,” The Journal of Immunology, vol. 183, no. 2, pp. 797–801, 2009. View at Publisher · View at Google Scholar · View at Scopus
  147. R. Rodrigues Dos Santos Jr., A. Sartori, V. L. Deperon Bonato et al., “Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression,” Clinical and Experimental Immunology, vol. 149, no. 3, pp. 570–578, 2007. View at Publisher · View at Google Scholar · View at Scopus
  148. D. Elias, H. Prigozin, N. Polak, M. Rapoport, A. W. Lohse, and I. R. Cohen, “Autoimmune diabetes induced by the β-cell toxin STZ: immunity to the 60- kDa heat shock protein and to insulin,” Diabetes, vol. 43, no. 8, pp. 992–998, 1994. View at Publisher · View at Google Scholar · View at Scopus
  149. A. Zanin-Zhorov, L. Cahalon, G. Tal, R. Margalit, O. Lider, and I. R. Cohen, “Heat shock protein 60 enhances CD4+CD25+ regulatory T cell function via innate TLR2 signaling,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 2022–2032, 2006. View at Publisher · View at Google Scholar · View at Scopus
  150. M. Saraiva, J. R. Christensen, M. Veldhoen, T. L. Murphy, K. M. Murphy, and A. O'Garra, “Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose,” Immunity, vol. 31, no. 2, pp. 209–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  151. M. H. Shaw, G. J. Freeman, M. F. Scott et al., “Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation,” Journal of Immunology, vol. 176, no. 12, pp. 7263–7271, 2006. View at Publisher · View at Google Scholar · View at Scopus
  152. R. Spolski and W. J. Leonard, “Interleukin-21: basic biology and implications for cancer and autoimmunity,” Annual Review of Immunology, vol. 26, pp. 57–79, 2008. View at Publisher · View at Google Scholar · View at Scopus
  153. R. Spolski, H.-P. Kim, W. Zhu, D. E. Levy, and W. J. Leonard, “IL-21 mediates suppressive effects via its induction of IL-10,” Journal of Immunology, vol. 182, no. 5, pp. 2859–2867, 2009. View at Publisher · View at Google Scholar · View at Scopus
  154. W. Cui, Y. Liu, J. S. Weinstein, J. Craft, and S. M. Kaech, “An interleukin-21- interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells,” Immunity, vol. 35, no. 5, pp. 792–805, 2011. View at Publisher · View at Google Scholar · View at Scopus
  155. J. A. Olson and S. C. Jameson, “Keeping STATs on memory CD8+ T cells,” Immunity, vol. 35, no. 5, pp. 663–665, 2011. View at Publisher · View at Google Scholar · View at Scopus
  156. K. E. Foulds, M. J. Rotte, and R. A. Seder, “IL-10 is required for optimal CD8 T cell memory following Listeria monocytogenes infection,” Journal of Immunology, vol. 177, no. 4, pp. 2565–2574, 2006. View at Publisher · View at Google Scholar · View at Scopus
  157. J. C. Cyktor, B. Carruthers, G. L. Beamer, and J. Turner, “Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infection,” PLoS ONE, vol. 8, no. 3, Article ID e58612, 2013. View at Publisher · View at Google Scholar · View at Scopus
  158. D. Sauma, P. Espejo, A. Ramirez, A. Fierro, M. Rosemblatt, and M. R. Bono, “Differential regulation of Notch ligands in dendritic cells upon interaction with T helper cells,” Scandinavian Journal of Immunology, vol. 74, no. 1, pp. 62–70, 2011. View at Publisher · View at Google Scholar · View at Scopus
  159. S. Rutz, M. Janke, N. Kassner, T. Hohnstein, M. Krueger, and A. Scheffold, “Notch regulates IL-10 production by T helper 1 cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 9, pp. 3497–3502, 2008. View at Publisher · View at Google Scholar · View at Scopus
  160. F. Auderset, M. Coutaz, and F. Tacchini-Cottier, “The role of notch in the differentiation of CD4+ T helper cells,” Current Topics in Microbiology and Immunology, vol. 360, pp. 115–134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  161. C. Helbig, R. Gentek, R. A. Backer et al., “Notch controls the magnitude of T helper cell responses by promoting cellular longevity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 23, pp. 9041–9046, 2012. View at Publisher · View at Google Scholar · View at Scopus
  162. L. Rivino, P. Gruarin, B. Häringer et al., “CCR6 is expressed on an IL-10-producing, autoreactive memory T cell population with context-dependent regulatory function,” Journal of Experimental Medicine, vol. 207, no. 3, pp. 565–577, 2010. View at Publisher · View at Google Scholar · View at Scopus
  163. S. Alas, C. Emmanouilides, and B. Bonavida, “Inhibition of interleukin 10 by Rituximab results in down-regulation of Bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis,” Clinical Cancer Research, vol. 7, no. 3, pp. 709–723, 2001. View at Google Scholar · View at Scopus
  164. Z. S. Boyd, A. Kriatchko, J. Yang, N. Agarwal, M. B. Wax, and R. V. Patil, “Interleukin-10 receptor signaling through STAT-3 regulates the apoptosis of retinal ganglion cells in response to stress,” Investigative Ophthalmology & Visual Science, vol. 44, no. 12, pp. 5206–5211, 2003. View at Publisher · View at Google Scholar · View at Scopus
  165. S. Sieg, C. King, Y. Huang, and D. Kaplan, “The role of interleukin-10 in the inhibition of T-cell proliferation and apoptosis mediated by parainfluenza virus type 3,” Journal of Virology, vol. 70, no. 7, pp. 4845–4848, 1996. View at Google Scholar · View at Scopus
  166. K. Taga, J. Chretien, B. Cherney, L. Diaz, M. Brown, and G. Tosato, “Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells,” Journal of Clinical Investigation, vol. 94, no. 1, pp. 251–260, 1994. View at Publisher · View at Google Scholar · View at Scopus
  167. S. Poitevin, S. B. H. K. Kechiche, C. Macé, and P. Nguyen, “IL-10 inhibits apoptosis and microvesiculation of human monocytes,” Journal of Thrombosis and Haemostasis, vol. 7, no. 7, pp. 1241–1243, 2009. View at Publisher · View at Google Scholar · View at Scopus
  168. H. Yang and S.-C. Chen, “The effect of interleukin-10 on apoptosis in macrophages stimulated by oxLDL,” European Journal of Pharmacology, vol. 657, no. 1–3, pp. 126–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  169. S. Dhingra, A. K. Bagchi, A. L. Ludke, A. K. Sharma, and P. K. Singal, “Akt regulates IL-10 mediated suppression of TNFα-induced cardiomyocyte apoptosis by upregulating stat3 phosphorylation,” PLoS ONE, vol. 6, no. 9, Article ID e25009, 2011. View at Publisher · View at Google Scholar · View at Scopus
  170. J. J. Donnelly, J. B. Ulmer, J. W. Shiver, and M. A. Liu, “DNA vaccines,” Annual Review of Immunology, vol. 15, pp. 617–648, 1997. View at Publisher · View at Google Scholar · View at Scopus
  171. J. J. Donnelly, B. Wahren, and M. A. Liu, “DNA vaccines: progress and challenges,” The Journal of Immunology, vol. 175, no. 2, pp. 633–639, 2005. View at Publisher · View at Google Scholar · View at Scopus
  172. V. L. D. Bonato, V. M. F. Lima, R. E. Tascon, D. B. Lowrie, and C. L. Silva, “Identification and characterization of protective T cells in hsp65 DNA- vaccinated and Mycobacterium tuberculosis-infected mice,” Infection and Immunity, vol. 66, no. 1, pp. 169–175, 1998. View at Google Scholar · View at Scopus
  173. V. L. D. Bonato, E. D. C. Gonçalves, E. G. Soares et al., “Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of CD8+ cells, interferon-γ recovery and reduction of lung injury,” Immunology, vol. 113, no. 1, pp. 130–138, 2004. View at Publisher · View at Google Scholar · View at Scopus
  174. D. B. Lowrie, R. E. Tascon, V. L. D. Bonato et al., “Therapy of tuberculosis in mice by DNA vaccination,” Nature, vol. 400, no. 6741, pp. 269–271, 1999. View at Publisher · View at Google Scholar · View at Scopus
  175. C. L. Silva, V. L. D. Bonato, V. M. F. Lima, L. H. Faccioli, and S. C. Leão, “Characterization of the memory/activated T cells that mediate the long-lived host response against tuberculosis after bacillus Calmette–Guérin or DNA vaccination,” Immunology, vol. 97, no. 4, pp. 573–581, 1999. View at Publisher · View at Google Scholar · View at Scopus
  176. W. van Eden, R. van der Zee, and B. Prakken, “Heat-shock proteins induce T-cell regulation of chronic inflammation,” Nature Reviews Immunology, vol. 5, no. 4, pp. 318–330, 2005. View at Publisher · View at Google Scholar · View at Scopus
  177. R. R. Santos Junior, A. Sartori, D. S. Lima et al., “DNA vaccine containing the mycobacterial hsp65 gene prevented insulitis in MLD-STZ diabetes,” Journal of Immune Based Therapies and Vaccines, vol. 7, article 4, 2009. View at Publisher · View at Google Scholar · View at Scopus
  178. S. F. Zorzella-Pezavento, C. P. Guerino, F. Chiuso-Minicucci et al., “BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis,” Clinical and Developmental Immunology, vol. 2013, Article ID 721383, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus